Related Experiment Videos
Factor VIII inhibitors: in vivo decrease of inhibitory activity during calcium infusion
Insights
Parenteral calcium administration reduced the activity of factor VIII inhibitors in patients. This effect was enhanced when calcium was given before and during factor VIII replacement therapy.
Area of Science:
- Hematology
- Biochemistry
Background:
- Factor VIII inhibitors pose a significant challenge in managing hemophilia and other bleeding disorders.
- Understanding modulators of factor VIII inhibitor activity is crucial for developing novel therapeutic strategies.
Observation:
- The study investigated the impact of parenteral calcium on factor VIII inhibitor activity in three patients.
- Patients received intravenous calcium, factor VIII replacement, or a combination of both.
Findings:
- Intravenous calcium infusion, particularly when administered before and during factor VIII replacement, led to a greater reduction in factor VIII inhibitor activity.
- This effect was confirmed using conventional coagulation assays and an agarose gel method.
Implications:
- Parenteral calcium may offer a novel therapeutic approach to mitigate factor VIII inhibitor activity.
- Further research into the calcium-factor VIII interaction could elucidate mechanisms relevant to bleeding disorders.
Abstract:
The effect of parenteral calcium on altering the activity of factor VIII inhibitors has been studied in three patients, two nonhemophiliacs and one hemophiliac. The patients were studied during both intravenous calcium infusion, factor VIII replacement, and combinations thereof. When compared to factor VIII replacement alone, a greater diminution of inhibitory activity was noted whenever calcium was infused prior to and during factor VIII replacement. This was demonstrated by both conventional coagulation assays and an agarose gel method. These observations could have therapeutic implications and may aid in further understanding the relationship of calcium to factor VIII and its inhibitor.